| Market Cap | ₹139Cr |
| ROE | 50.81% |
| P/E Ratio(TTM) | -5.70 |
| EPS(TTM) | -2.94 |
| P/B Ratio | 0.00 |
| Dividend Yield | 0.00% |
| Industry P/E | 33.22 |
| Book Value | -10.37 |
| Debt to Equity | -8.01 |
| Face Value | 2 |
| Parent Organisation | Vivimed Labs Limited |
| Managing Director | Mr. Santosh Varalwar |
| NSE Symbol | VIVIMEDLAB |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 39.61 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 32.46 | ||
| Wockhardt | NA (0.00%) | -452.80 | ||
| Cohance Lifesciences | NA (0.00%) | 63.92 |